MV Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.96K Buy
32
+1
+3% +$100 ﹤0.01% 703
2025
Q4
$3.17K Hold
31
﹤0.01% 660
2025
Q3
$1.94K Hold
31
﹤0.01% 714
2025
Q2
$1.61K Buy
31
+11
+55% +$491 ﹤0.01% 725
2025
Q1
$852 Buy
20
+1
+5% +$43 ﹤0.01% 764
2024
Q4
$581 Buy
19
+10
+111% +$281 ﹤0.01% 796
2024
Q3
$207 Sell
9
-4
-31% -$113 ﹤0.01% 892
2024
Q2
$376 Buy
13
+7
+117% +$163 ﹤0.01% 753
2024
Q1
$124 Buy
6
+5
+500% +$107 ﹤0.01% 761
2023
Q4
$28 Buy
+1
New +$26 ﹤0.01% 764

Other funds holding GH

MV Capital Management's GH Position: Q1 2026 in Review

MV Capital Management increased its Guardant Health (GH) stake by 3.2% in Q1 2026, buying an estimated $100 and bringing the position to 32 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

MV Capital Management first reported a position in GH in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.17K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • MV Capital Management held 32 shares of Guardant Health worth $2.96K as of Q1 2026.
  • MV Capital Management bought 1 Guardant Health share in Q1 2026, an estimated $100.
  • Guardant Health made up ﹤0.01% of MV Capital Management's portfolio in Q1 2026, its #703 holding.
  • MV Capital Management first reported a position in Guardant Health in Q4 2023 and has held it in 10 quarters since.
  • MV Capital Management's Guardant Health position peaked at $3.17K in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on MV Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.